Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)

dc.contributor.authorSurmeli, Z
dc.contributor.authorBozkurt, E
dc.contributor.authorOzer, O
dc.contributor.authorAtmaca, H
dc.contributor.authorKisim, A
dc.contributor.authorUzunoglu, S
dc.contributor.authorUslu, R
dc.contributor.authorKaraca, B
dc.date.accessioned2025-04-10T10:33:19Z
dc.date.available2025-04-10T10:33:19Z
dc.identifier.e-issn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttp://hdl.handle.net/20.500.14701/39596
dc.language.isoEnglish
dc.titleEnhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)
dc.typeMeeting Abstract

Files